Boehringer opens China tech center
Print Edition
German pharmaceutical company Boehringer Ingelheim yesterday unveiled its External Innovation Hub in Shanghai.
In the next five years, the company will invest 451 million euros (US$507.9 million) in China in clinical research, production expansion and other research partnerships.
鈥淏oehringer Ingelheim will continue to increase investment in China, including setting up the External Innovation Hub.
鈥淭he hub will become one of Boehringer Ingelheim鈥檚 strategic pillars,鈥 said Felix Gutsche, president and CEO of Boehringer Ingelheim China.
The company expects to have 71 new products approved in China by 2030.
鈥淐OVID-19 has highlighted the importance of digital services.
鈥淎nd our latest digital initiative hopes to integrate all the methodology and technology with real business needs,鈥 he told Shanghai Daily.
鈥淐hina is the first market to see business rebound after the coronavirus outbreak.鈥
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
